Find a Doctor

Physician Photo

Dennis C. Sgroi, MD

Associate Pathologist

Director of Breast Pathology

Departments
Department of Pathology

Specialties

  • Cancer Center
  • Breast Cancer
Clinical Interests
Breast pathology
Locations
Boston: Massachusetts General Hospital
Medical Education
MD, University of Connecticut School of Medicine
Residency, Massachusetts General Hospital
Fellowship, Massachusetts General Hospital
Board Certifications
Anatomic Pathology, American Board of Pathology
Gender
Male
Patient Age Group
Adult
Accepting New Patients
Yes

Biography

Professor of Pathology
Harvard Medical School

Dr. Sgroi is a Professor of Pathology at Harvard Medical School, the Director of Breast Pathology and a Member and Principal Investigator in the Division of Molecular Pathology Research and Center for Cancer Research at the Massachusetts General Hospital.  Dr Sgroi received his undergraduate degree from Bowdoin College and his medical degree from the University of Connecticut School of Medicine.  After completing a residency in anatomic pathology at Massachusetts General Hospital, Dr Sgroi completed a postdoctoral research fellowship in molecular pathology under the direction of Dr. Ivan Stamenkovic at Massachusetts General Hospital. His laboratory investigates the molecular genetic basis of human breast cancer and has utilized gene expression and proteomic technologies to better understand breast cancer progression. Dr Sgroi has shown that gene expression alterations are powerful predictors of breast cancer outcome and therapeutic response. His laboratory is currently focusing on determining the clinical utility of the HOXB13:IL17BR and MGI biomarkers in estrogen receptor-positive,lymph node negative breast cancer patients, and understanding the molecular functional role of HOXB13 and IL17BR as it relates to anti-hormonal therapeutic response.

ResearchHuman Breast Cancer Anti-Hormonal Resistance

See details at the Sgroi Lab.

Gene-expression-based biomarker predicts long-term risk of breast cancer recurrence

A comparison of three methods of predicting recurrence risk in women treated for estrogen-receptor-positive breast cancer finds that only the breast cancer index – a biomarker based on the expression levels of seven tumor-specific genes – accurately identifies patients who continue to be at risk after five years of estrogen-blocking treatment.

149 13th Street
Charlestown, MA 02129-2020

Phone: 617-726-5697
Fax: 617-726-5684

149 13th Street
Charlestown, MA 02129-2020

Phone: 617-726-5697
Fax: 617-726-5684

Request a new patient appointment

Call the Massachusetts General Hospital physician referral service at 800-711-4644.

Insurance plans - what you need to know

Mass General accepts most health insurance plans. Find out what you need to know before coming to Mass General.

Directions to Mass General

Driving to Mass General? Get driving directions or locate a parking lot on the hospital's main campus.